A detailed history of Winton Group LTD transactions in Natera, Inc. stock. As of the latest transaction made, Winton Group LTD holds 8,133 shares of NTRA stock, worth $907,968. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,133
Holding current value
$907,968
% of portfolio
0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$59.21 - $92.9 $481,554 - $755,555
8,133 New
8,133 $743,000
Q1 2023

May 12, 2023

BUY
$36.57 - $58.29 $11,080 - $17,661
303 Added 1.96%
15,754 $874,000
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $158,343 - $222,014
4,634 Added 42.84%
15,451 $620,000
Q3 2022

Nov 10, 2022

SELL
$36.93 - $56.68 $324,171 - $497,537
-8,778 Reduced 44.8%
10,817 $474,000
Q2 2022

Aug 10, 2022

BUY
$28.13 - $44.54 $93,616 - $148,229
3,328 Added 20.46%
19,595 $694,000
Q1 2022

May 11, 2022

BUY
$30.32 - $91.33 $218,394 - $657,849
7,203 Added 79.47%
16,267 $662,000
Q4 2021

Feb 10, 2022

SELL
$86.26 - $119.0 $69,353 - $95,676
-804 Reduced 8.15%
9,064 $846,000
Q3 2021

Oct 28, 2021

SELL
$100.17 - $126.36 $200,139 - $252,467
-1,998 Reduced 16.84%
9,868 $1.1 Million
Q2 2021

Aug 10, 2021

SELL
$86.05 - $119.72 $53,953 - $75,064
-627 Reduced 5.02%
11,866 $1.35 Million
Q1 2021

Jul 21, 2021

SELL
$91.47 - $124.36 $488,266 - $663,833
-5,338 Reduced 29.94%
12,493 $1.27 Million
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $2.69 Million - $4.5 Million
-40,307 Reduced 69.33%
17,831 $1.78 Million
Q3 2020

Oct 30, 2020

BUY
$45.89 - $72.67 $2.67 Million - $4.22 Million
58,138 New
58,138 $4.2 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.